difference in tirzepatide and ozempic vs. Tirzepatide: Similarities & Differences Tirzepatide vs. Semaglutide: Key Differences

The only available oral GLP-1 medication is semaglutide (Rybelsus), which is FDA-approved for type 2 diabetes but not weight loss

Gharpure KM, Wu SY, Li C, Lopez-Berestein G, Sood AK

Mechanism of Action: Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist , meaning it activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors

The most common GLP-1 receptor agonists on the market include medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)

Over 40 years of research and clinical use have established that it is well tolerated with minimal adverse effects at recommended doses

Greater Consumer Protection: By centralizing the market around official, FDA-regulated medications, consumers benefit from consistent dosing, verified safety, and comprehensive post-market surveillance